Initial Management of Chronic Pancreatitis
The initial management of chronic pancreatitis should focus on three core pillars: adequate pain control, nutritional support with normal food supplemented by pancreatic enzyme replacement therapy (PERT), and addressing the underlying etiology. 1
Pain Management
- Start with conventional analgesics including NSAIDs and weak opioids such as tramadol as first-line therapy 2
- For severe pain not responding to conventional analgesics, consider epidural analgesia 1
- A trial of pancreatic enzymes and antioxidants (combination of multivitamins, selenium, and methionine) can control pain symptoms in up to 50% of patients 2
- Consider endoscopic or surgical drainage procedures for patients with pancreatic ductal obstruction due to stones or strictures who fail medical management 2
Nutritional Support and Dietary Modifications
- More than 80% of patients can be managed adequately with normal food supplemented by pancreatic enzymes 1
- Implement a low-fat diet with less than 30% of total energy intake from fat, preferably from vegetable sources, to minimize pancreatic stimulation 1
- Early oral feeding is strongly recommended rather than keeping patients nil per os 1
- For patients unable to tolerate adequate oral intake (approximately 10-15% of patients), add oral nutritional supplements 1
- Enteral tube feeding is indicated in only approximately 5% of patients, typically those with severe malnutrition or persistent pain with oral intake 1
Pancreatic Enzyme Replacement Therapy (PERT)
- PERT is the mainstay of nutritional management for chronic pancreatitis with exocrine insufficiency 1
- Early identification and treatment of steatorrhea with PERT is key to preventing malnutrition 1
- Monitor for signs of malabsorption including steatorrhea, weight loss, and fat-soluble vitamin deficiencies 1
Management of Exocrine Insufficiency
- Supplement fat-soluble vitamins (A, D, E, K) in patients with documented deficiencies 1
- Consider calcium and vitamin D supplementation to prevent osteoporosis/osteopenia, which affects approximately two-thirds of chronic pancreatitis patients 1
- Regular monitoring for vitamin deficiencies is essential, particularly fat-soluble vitamins 1
Management of Endocrine Insufficiency
- Monitor for development of type 3c (pancreatogenic) diabetes, which occurs in 38-40% of patients later in the disease process 1, 2
- Type 3c diabetes management requires special consideration due to concurrent decreased glucagon secretion and increased risk of hypoglycemia 1
Addressing Underlying Etiology
- For alcohol-induced chronic pancreatitis, complete alcohol cessation is essential to prevent disease progression 1
- Smoking cessation is critical, as smoking is strongly associated with chronic pancreatitis (OR 4.59 for >35 pack-years) 2
- For gallstone-related pancreatitis, consider appropriate biliary interventions 1
Common Pitfalls to Avoid
- Do not delay PERT initiation—exocrine insufficiency develops in 30-48% of patients and early treatment prevents malnutrition 2
- Do not overlook vitamin deficiencies, particularly fat-soluble vitamins, which are frequently underrecognized and undertreated 3
- Do not use total parenteral nutrition routinely—the majority of patients can be managed with oral intake and enzyme supplementation 4
- Do not forget to screen for osteoporosis, as bone disease is highly prevalent in this population 1